Deciphera Pharmaceuticals Stock (NASDAQ: DCPH) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 513.843K |
Day Range | - - - |
52 Wk Range | 9.900 - 17.730 |
Market Cap | $1.181B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 9.99% |
Days to Cover | 12.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Deciphera Pharmaceuticals (NASDAQ: DCPH) through any online brokerage.
Other companies in Deciphera Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).
The latest price target for Deciphera Pharmaceuticals (NASDAQ: DCPH) was reported by JP Morgan on Wednesday, March 20, 2024. The analyst firm set a price target for 16.00 expecting DCPH to rise to within 12 months (a possible 9.44% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Deciphera Pharmaceuticals (NASDAQ: DCPH) is $14.62 last updated April 24, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.